Granules India shares gain as Hyderabad facility gets US FDA EIR

• Granules India's Hyderabad facility received an Establishment Inspection Report (EIR) from the US FDA.
• The EIR confirms the facility's compliance with FDA quality standards and regulatory requirements.
• Granules Life Sciences, a wholly owned subsidiary, was the subject of the FDA inspection.
• The company achieved an "A" rating in Climate Change and "B" ratings in Water Security and Forests.
• Granules also inaugurated two advanced Centres of Excellence at IIT Hyderabad.

Why It Matters: FDA approval ensures product quality and market access for Granules India's products.